Open
You're reading the free version. Trader adds the live tape and alerts. Start tracking

Price with disclosed trades

Daily closes, past year · marks sit on transaction dates, sized by value

67 trades

Disclosure transactions for Heron Therapeutics
Reporting person Filed Transaction Transaction value Source Actions
Duarte Ira EVP, Chief Financial Officer Jul 20, 2026 1-day lag Exercise Jul 19, 2026 Not reported Reported range SEC Form 4 View filing
Duarte Ira EVP, Chief Financial Officer Jul 20, 2026 1-day lag Exercise Jul 19, 2026 $0 Filed shares x price SEC Form 4 View filing
Duarte Ira EVP, Chief Financial Officer Jun 17, 2026 1-day lag Exercise Jun 16, 2026 Not reported Reported range SEC Form 4 View filing
Duarte Ira EVP, Chief Financial Officer Jun 17, 2026 1-day lag Exercise Jun 16, 2026 $0 Filed shares x price SEC Form 4 View filing
Duarte Ira EVP, Chief Financial Officer Jun 17, 2026 1-day lag Disposition Jun 16, 2026 $1.35K Filed shares x price SEC Form 4 View filing
Forbes William P EVP, Chief Development Officer Jun 8, 2026 2-day lag Exercise Jun 6, 2026 Not reported Reported range SEC Form 4 View filing
Forbes William P EVP, Chief Development Officer Jun 8, 2026 2-day lag Exercise Jun 6, 2026 $0 Filed shares x price SEC Form 4 View filing
Duarte Ira EVP, Chief Financial Officer
Exercise
Reported value range
Not reported 3,874 shares
Traded
Jul 19, 2026
Filed
Jul 20, 2026
Duarte Ira EVP, Chief Financial Officer
Exercise
Calculated transaction value
$0 3,874 shares @ $0
Traded
Jul 19, 2026
Filed
Jul 20, 2026
Duarte Ira EVP, Chief Financial Officer
Exercise
Reported value range
Not reported 12,500 shares
Traded
Jun 16, 2026
Filed
Jun 17, 2026
Duarte Ira EVP, Chief Financial Officer
Exercise
Calculated transaction value
$0 12,500 shares @ $0
Traded
Jun 16, 2026
Filed
Jun 17, 2026
Duarte Ira EVP, Chief Financial Officer
Disposition
Calculated transaction value
$1.35K 3,555 shares @ $0.38
Traded
Jun 16, 2026
Filed
Jun 17, 2026
Forbes William P EVP, Chief Development Officer
Exercise
Reported value range
Not reported 12,500 shares
Traded
Jun 6, 2026
Filed
Jun 8, 2026
Forbes William P EVP, Chief Development Officer
Exercise
Calculated transaction value
$0 12,500 shares @ $0
Traded
Jun 6, 2026
Filed
Jun 8, 2026